BridgeMD
New treatment option for Lung Lesions
Official title A Study of Contrast-enhanced EBUS in Lung Lesions and Intrathoracic Lymph Nodes
ClinicalTrials.gov ID: NCT07060378
What this study is testing
- What it's testing
- Exploring the Clinical Application Value of Contrast Enhancement Features in CE-EBUS Images for the Diagnosis of Pulmonary Lesions and Intrapulmonary Lymph Nodes
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 to 90
You may be able to join if
- Age \>18 years old；
- Enlargement of at least one intrathoracic LN (short diameter \> 1 cm) or central parenchymal lung lesions adjacent to the airway detected on chest...
- CP-EBUS-TBNA is required to determine the diagnosis or staging, the patient agreed to undergo CE-EBUS, and there were no contraindications to...
- Patients who have good compliance and sign informed consent.
You likely can't join if
- Patients with known hypersensitivity to ultrasound contrast components;
- Patients with severe pulmonary hypertension (pulmonary artery pressure \> 90 mmHg);
- Patients with angina pectoris, acute coronary syndrome, clinically unstable ischemic heart disease, heart failure, cardiac dysfunction, and cardiac...
- Patients with uncontrolled essential hypertension and adults with respiratory distress syndrome;
- Pregnant or lactating women；
- Patients with contraindications to bronchoscopy；
See the full eligibility criteria
- Age \>18 years old；
- Enlargement of at least one intrathoracic LN (short diameter \> 1 cm) or central parenchymal lung lesions adjacent to the airway detected on chest CT, or increased fluorodeoxyglucose uptake in at least one intrathoracic...
- CP-EBUS-TBNA is required to determine the diagnosis or staging, the patient agreed to undergo CE-EBUS, and there were no contraindications to EBUS-TBNA;
- Patients who have good compliance and sign informed consent.
- Patients with known hypersensitivity to ultrasound contrast components;
- Patients with severe pulmonary hypertension (pulmonary artery pressure \> 90 mmHg);
- Patients with angina pectoris, acute coronary syndrome, clinically unstable ischemic heart disease, heart failure, cardiac dysfunction, and cardiac disease with right-to-left shunting;
- Patients with uncontrolled essential hypertension and adults with respiratory distress syndrome;
- Pregnant or lactating women；
- Patients with contraindications to bronchoscopy；
- Patients with other conditions that, in the opinion of the investigator, make the patient unsuitable for the study.
The study team makes the final eligibility decision.
Where it's taking place
- Shanghai, Shanghai Municipality, China
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 18 years to 90 years. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Shanghai, Shanghai Municipality, China. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.